Zocon 50 DT Tablet contains Fluconazole 50 mg, an antifungal agent belonging to the triazole class. It is indicated for the treatment and prevention of a variety of fungal infections caused by susceptible strains of Candida and Cryptococcus species. Fluconazole acts by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase, which is essential for converting lanosterol to ergosterol, a critical component of the fungal cell membrane. This disruption leads to increased membrane permeability and ultimately fungal cell death. Zocon 50 DT is effective in managing oropharyngeal and esophageal candidiasis, vaginal candidiasis, and systemic fungal infections such as cryptococcal meningitis. The tablet is designed as a dispersible formulation, facilitating ease of administration, especially in patients with swallowing difficulties. It is generally well tolerated, with common adverse effects including headache, nausea, abdominal pain, and rash. Caution is advised in patients with hepatic impairment or those receiving concomitant medications metabolized by the cytochrome P450 system due to potential drug interactions. Dosage and duration of therapy should be individualized based on the severity and type of infection, as well as patient-specific factors. Zocon 50 DT should be used under medical supervision to ensure optimal efficacy and safety.